Mross, K., 		Frost, A., 		Scheulen, M., 		Krauss, J., 		Strumberg, D., 		Schultheiss, B., 		Fasol, U., 		Büchert, M., 		Krätzschmer, J., 		Delesen, H., 		Rajagopalan, P., & 		Christensen, O.
(2011).
 Phase I study of telatinib (BAY 57-9352): analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer.
<em>Vascular Cell, 3</em>(1), 16.
doi:10.1186/2045-824X-3-16